InnovAge (INNV) 10% Owner LP Sells $14M of Stock

Ignite Aggregator L.P. sold 1.5 million shares of InnovAge Holding Corp. (INNV) on October 21, 2026, at a price of $9.25 per share. According to a Form 4 filing with the Securities and Exchange Commission, the transaction totaled roughly $13.88 million and trimmed the owner's stake by about 1.5%. Following the sale, the entity still holds 101,076,555 shares.

INNV InnovAge Holding Corp.

$9.55 ▲ +84.01% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Inside Ignite Aggregator's InnovAge Trade

The 10% owner disposed of the shares in an open market transaction, reducing its overall holdings in the healthcare provider. The filing showed the sale price at $9.25 per share, bringing the total value to $13.88 million. This trade reduced the entity's direct ownership position by a 1.46% change from its prior total.

Other Institutional Activity in InnovAge

Other large financial institutions have also adjusted their positions in the medical care facilities provider. Federated Hermes, Inc. grew its holdings by 1,899,133 shares, ending with 1,903,713 shares worth about $18.18 million. Arrowstreet Capital, Limited Partnership added 251,196 shares to hold 668,742 shares valued at approximately $6.39 million. Algert Global, LLC increased its stake by 563,735 shares to finish with 630,520 shares worth around $6.02 million. Acadian Asset Management, LLC picked up 207,671 shares, growing its position to 390,850 shares valued at about $3.73 million.

InnovAge Holding Corp. Stock Up 4.5%

InnovAge shares recently traded around $9.55 as of October 23, 2026. The stock sits below its 50-day moving average of $10.02, but remains above its 200-day moving average of $8.95. Over the past year, shares have traded as low as $3.94 and as high as $12.64. The company carries a market capitalization of roughly $1.30 billion.

Recent Earnings

InnovAge posted trailing-twelve-month revenue of $989.7 million alongside an earnings per share of minus $0.02. The firm reported a net profit margin of -0.3% and a return on equity of -0.3%. The company's next earnings report is scheduled for November 3, 2026.

Insider Buying and Selling at InnovAge Holding Corp.

Insider activity has remained active in recent months. On September 24, 2026, TCO Group Holdings L.P. sold 10 million shares at $9.25 each for a total of $92.50 million. Ignite Aggregator L.P. also sold 10 million shares on September 24, 2026, at $9.25 per share. Welsh, Carson, Anderson & Stowe XII, L.P. parted with 10 million shares on the same day at $8.84 apiece, totaling $88.40 million. Officer Nicole Damato sold 23,814 shares at $8.70 per share on September 25, 2026, valued at $207,182.

Analysts Set New Price Targets

Keybanc upgraded the stock to an Overweight rating with a $13.00 price target on August 21, 2026. The firm later maintained its Overweight rating on September 9, 2026, while raising its price target to $14.00. Across the community, the stock holds a consensus mean price target of $12.00 based on two analyst opinions.

About InnovAge Holding Corp.

InnovAge Holding Corp. operates in the healthcare sector, managing and providing medical and support services for older adults. The company centers its operations around the Program of All-Inclusive Care for the Elderly, known as PACE, delivering coordinated care options to seniors in community settings. This setup allows older individuals to receive comprehensive medical care while maintaining their independence.

Bottom Line

Investors will look toward InnovAge's upcoming earnings release on November 3, 2026, for further updates on the company's financial trajectory. Form 4 filings will continue to provide transparency into how major stakeholders manage their remaining positions.